Franklin Biotechnology Discv B Acc $

Performance History31/12/2016
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv B Acc $
Fund31.7100.046.838.8-28.5
+/-Cat-1.45.02.8-4.80.5
+/-Idx-19.7-7.02.4-5.4-6.0
 
Key Stats
NAV
23/01/2017
 USD 22.38
Day Change -1.53%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394881
Fund Size (Mil)
31/12/2016
 USD 2182.40
Share Class Size (Mil)
31/12/2016
 USD 23.10
Max Initial Charge -
Ongoing Charge
08/06/2016
  3.12%
Investment Objective: Franklin Biotechnology Discv B Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns23/01/2017
YTD1.11
3 Years Annualised7.04
5 Years Annualised29.49
10 Years Annualised17.74
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
03/04/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv B Acc $31/10/2016
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks93.160.0093.16
Bonds0.000.000.00
Cash5.150.005.15
Other1.690.001.69
Top 5 Regions%
United States96.68
United Kingdom1.63
Middle East0.69
Eurozone0.57
Canada0.22
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.61
Biogen IncHealthcareHealthcare7.88
Tesaro IncHealthcareHealthcare7.33
Gilead Sciences IncHealthcareHealthcare7.28
Incyte CorpHealthcareHealthcare4.66
Franklin Biotechnology Discv B Acc $